Clinical Development

toclinco has more than 20 years' experience in the preparation of clinical development plans (CDPs) of medicinal products classified as:

  • Pharmaceuticals
  • Biotechnological medicinal products (monoclonal antibodies)
  • Biosimilars
  • Human blood derived products (plasma proteins)
  • Advanced therapy medicinal products (ATMPs)
  • Orphan medicinal products
  • Medical devices
  • Phytomedicines / herbal products.

These CDPs are based on current guidelines (ICH, scientific guidelines, indication guidelines), guidance documents, pharmacological profiles of the medicinal products, competitor and economical environments as well as  systematic assessments of the scientific literature (database searches) and benefit-risk considerations.